Carisma Therapeutics (OTCID: CARM) to voluntarily delist from Nasdaq, Board approved decision.
Philadelphia-based company Carisma Therapeutics Inc. (OTCID: CARM) revealed plans to voluntarily delist its common stock from The Nasdaq Stock Market LLC. The decision was approved by the Board of Directors and marks a significant move for the Company. The delisting process signifies a strategic shift, and shareholders will need to consider their next steps as a result.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments